SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical, Inc., a leading developer of innovative medical devices for complex cardiovascular disease, has announced the opening of its European subsidiary ...

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Reflow Medical, Inc. announces that the first patients have been enrolled in its DEEPER OUS clinical trial using the Temporary Spur Stent System. DEEPER OUS is a ...

Reflow Medical, Inc., a leading developer of innovative medical devices focused on complex cardiovascular disease, announced that the U.S. Food and Drug Administration (FDA) has granted De Novo ...

Reflow Medical, a cardiovascular disease-focused medical device company, today announced it has received a CE Mark for the Bare Temporary Spur Stent System to treat de novo or restenotic lesions in ...

Within the last 24 months, I have financial relationship(s) or affiliation(s) with a manufacturer, marketer, reseller, or distributor of a healthcare product or service involved in the management of ...

Reflow Medical, Inc. announced that it has received FDA commercial clearance for its coraCatheters™, a complete line of state-of-the-art microcatheters engineered to access and cross complex and ...

SCOTTSDALE, Ariz., March 20, 2025 /PRNewswire/ -- Anuncia Medical, Inc. ("Anuncia"), a pioneering company in CSF management and neurocritical care, has received Breakthrough Device Designation from ...

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aurora Spine, ICU Medical Lungpacer Medical, Reflow Medical, Skincure Oncology, Smiths Medical.

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accuray, Aidoc Medical, Alcon, Holberg EEG, Labcorp, Natus, Reflow Medical, Relief ...